English
Français
Deutsch
العربية
Português
Español
简体中文

News
Home / News
  • Goldsite COVID-19 SARS-Cov-2 Antigen Kit (Colloidal Gold) is authorized by The Paul-Ehrlich-Institut (PEI) in Germany for its excellent performance, another groundbreaking moment marks it’s recognized by global regulatory community, with excellent quality, as always.Previously, Goldsite's new corona
  • On March 12, Shenzhen Goldsite’s SARS-CoV-2 IgM / IgG kit (using time-resolved fluorescence immunoassay) has been approvedby EU with CE marked.CE stands for CONFORMITE EUROPEENNE. The CE mark indicates that the product complies with all relevant directives of the European Commission and symbolizes c
  • Goldsite contains 21 years of experience in IVD reagent and instrument manufacturing and developing. We care for pets. Our team is working every day to better understand and address the real-world challenges faced by our customers who raise and care for pets. To help pets to live longer and healthie
  • GPP-100, Goldsite’s eye-catcher innovative specific protein product, starts its journey to Sweden in December 2019. Since it was launched in 2018, GPP-100 has been installed in many countries i.e. India, Philippine, Qatar, SA, Romania etc. Its excellent and stable performance has impressed clients f
  • The annual medical feast MEDICA International Medical Exhibition, opened on November 18, 2019, in Düsseldorf, Germany, attracting exhibitors and visitors from more than 100 countries and regions around the world. As the most well-known comprehensive medical exhibition in the world, this exhibition h
Goldsite Diagnostics Inc., founded in 1999, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents.

Get in touch

    (+86)-755-26890807

        (+86)-755-26897973
   export@goldsite.com.cn

 

Copyright © 1999- 2023 Goldsite Diagnostics Inc., All rights reserved.   Sitemap